Johnson & Johnson Vaccine Participants Goes Ill
CORONAVIRUS VACCINE – Participants of the vaccine trial for Johnson & Johnson developed an unexplained illness, causing a halt in the study.
Currently, the coronavirus pandemic has infected more than 3 million people across the world. As such, researchers and scientists are racing to develop a vaccine for the deadly disease.
Among the leading names in terms of vaccine research was Johnson & Johnson. However, due to unforeseen circumstances, the company had to suspend studies on the vaccine.
READ: COVID-19 Vaccine Human Testing Eyed On September
In a public statement, Johnson & Johnson said:
We have temporarily paused further dosing in all our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant
This suspension meant that the online enrollment system was shut down for 60,000-patient clinical tests as the independent patient safety committee is gathered. Still, the company said instances such as this were “an expected part of any clinical study, especially large studies”.
J&J’s clinical trial for their COVID-19 vaccine candidate had already been in its third stage and had begun recruiting volunteers since late September. Furthermore, they aimed to gather 60,000 participants across over 200 sites in the United States and worldwide.
Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.
Like this article? READ ALSO: Trump Feels “Powerful” Following COVID-19 Recovery